Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Essential Head Tremor
2015-000162-59Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential tremor (ET) comparing BOTOX with Placebo (2 arms). Started Jun 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on 2015-000162-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000162-59.